Diagnostic Radioisotopes Market

Diagnostic Radioisotopes Market, By Radioisotope, By Application, By Imaging Modality, By End User, By Indication, By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

The global market for diagnostic radioisotopes is experiencing significant growth due to the increasing prevalence of chronic diseases, advancements in medical imaging technology, and the rising demand for accurate diagnostic procedures. Diagnostic radioisotopes are radioactive substances that are used in medical imaging to diagnose various diseases and conditions. These isotopes emit radiation that can be detected by imaging devices, allowing healthcare professionals to visualize and analyze the internal structures of the body.

Market Dynamics:

The market dynamics of the global diagnostic radioisotopes market are influenced by several factors. The increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders is driving the demand for diagnostic radioisotopes. These isotopes are used in various imaging techniques such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and gamma cameras to detect and diagnose these diseases.

However, there are certain restraints that may hinder the growth of the market. The high cost of diagnostic radioisotopes and the stringent regulatory requirements for their production and use pose challenges for market growth. Additionally, the limited availability of radioisotopes and the short half-life of some isotopes may limit their use in certain diagnostic procedures.

Despite these challenges, the market presents several opportunities for growth. The increasing adoption of hybrid imaging techniques, such as PET/CT and SPECT/CT, is expected to drive the demand for diagnostic radioisotopes. Moreover, the development of novel radioisotopes and radiopharmaceuticals, as well as advancements in imaging technology, are expected to create new opportunities in the market.

Key features of the study:

• This report provides in-depth analysis of the global diagnostic radioisotopes market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global diagnostic radioisotopes market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GE Healthcare, Siemens Healthineers, Philips Healthcare , Cardinal Health , Lantheus Medical Imaging, Bayer AG, Bracco Imaging, Eczacıbaşı-Monrol Nuclear Products , Nordion, Advanced Accelerator Applications, NTP Radioisotopes, Curium Pharma, Jubilant Life Sciences Ltd , IRE – IRE ELiT – Instituto de Pesquisas Energéticas e Nucleares, Australian Nuclear Science and Technology Organisation (ANSTO), Eckert & Ziegler Radiopharma GmbH, Isotopia Molecular Imaging Ltd. , Institute of Atomic Energy of Bangladesh , Rosatom State Atomic Energy Corporation, Board of Radiation and Isotope Technology (BRIT)
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global diagnostic radioisotopes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic radioisotopes market

Detailed Segmentation:

• Global Diagnostic Radioisotopes Market, By Radioisotope
• Technetium-99m
• Thallium-201
• Gallium-67
• Iodine-123
• FDG
• Rubidium-82
• Others
• Global Diagnostic Radioisotopes Market, By Application
• Diagnostic Application
• Therapeutic Application
• Global Diagnostic Radioisotopes Market, By Imaging Modality
• SPECT
• PET
• Beta Emitters
• Global Diagnostic Radioisotopes Market, By End User
• Hospitals
• Diagnostic Centers
• Research Institutes
• Others
• Global Diagnostic Radioisotopes Market, By Indication
• Cardiology
• Oncology
• Neurology
• Others
• Global Diagnostic Radioisotopes Market, By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
• Company Profile:
• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Cardinal Health
• Lantheus Medical Imaging
• Bayer AG
• Bracco Imaging
• Eczacıbaşı-Monrol Nuclear Products
• Nordion
• Advanced Accelerator Applications
• NTP Radioisotopes
• Curium Pharma
• Jubilant Life Sciences Ltd
• IRE – IRE ELiT – Instituto de Pesquisas Energéticas e Nucleares
• Australian Nuclear Science and Technology Organisation (ANSTO)
• Eckert & Ziegler Radiopharma GmbH
• Isotopia Molecular Imaging Ltd.
• Institute of Atomic Energy of Bangladesh
• Rosatom State Atomic Energy Corporation
• Board of Radiation and Isotope Technology (BRIT)